HALOZYME THERAPEUTICS INC (HTI) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 398 transactions totaling $44.8M, demonstrating a bullish sentiment with $36.8M in net insider flow. The most recent transaction on Sep 17, 2007 involved a purchase of 238,020 shares valued at $2.1M.
No significant insider buying has been recorded for HTI in the recent period.
No significant insider selling has been recorded for HTI in the recent period.
Based on recent SEC filings, insider sentiment for HTI is bullish with an Insider Alignment Score of 91/100 and a net flow of $36.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at HALOZYME THERAPEUTICS INC (HTI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading HTI stock, having executed 398 transactions in the past 90 days. The most active insider is Randal J. Kirk (Executive), who has made 29 transactions totaling $40.9M.
Get notified when executives and directors at HTI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 17, 2007 | J. Kirk Randal | Executive | Purchase | 238,020 | $8.66 | $2.1M | Large |
| Sep 14, 2007 | J. Kirk Randal | Executive | Purchase | 127,693 | $8.71 | $1.1M | Large |
| Sep 13, 2007 | J. Kirk Randal | Executive | Purchase | 65,713 | $8.74 | $574.3K | Large |
| May 30, 2007 | J. Kirk Randal | Executive | Purchase | 3,500,000 | $9.17 | $32.1M | Large |
| May 15, 2007 | Stuart Patton John | Executive | Award | 15,000 | $10.37 | $155.6K | |
| May 15, 2007 | Engler Robert | Executive | Award | 15,000 | $10.37 | $155.6K | |
| May 15, 2007 | J. Kelley Kenneth | Executive | Award | 15,000 | $10.37 | $155.6K | |
| May 15, 2007 | T. Thornton Steven | Executive | Award | 15,000 | $10.37 | $155.6K | |
| May 15, 2007 | Matsui Connie | Executive | Award | 15,000 | $10.37 | $155.6K | |
| May 15, 2007 | Stuart Patton John | Executive | Award | 15,000 | $10.37 | $155.6K | |
| May 15, 2007 | J. Kirk Randal | Executive | Award | 15,000 | $10.37 | $155.6K | |
| May 15, 2007 | E. Falberg Kathryn | Executive | Award | 15,000 | $10.37 | $155.6K | |
| May 14, 2007 | A. Ramsay David | Executive | Sale | 10,000 | $10.19 | $101.9K | |
| May 7, 2007 | J. Kelley Kenneth | Executive | Sale | 3,076 | $10.38 | $31.9K | |
| May 7, 2007 | J. Kelley Kenneth | Executive | Option Exercise | 12,500 | $4.10 | $51.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 34 | $40.8M | 86.3% |
Sale(S) | 336 | $4.0M | 8.5% |
Award(A) | 13 | $1.5M | 3.1% |
Exercise(M) | 12 | $914.2K | 1.9% |
Gift(G) | 3 | $115.6K | 0.2% |
Insiders at HALOZYME THERAPEUTICS INC are accumulating shares at an accelerated pace. With 11 insiders making 398 transactions totaling $40.8M in purchases versus $4.0M in sales, the net buying activity of $36.8M signals strong executive confidence. Randal J. Kirk (Executive) leads the buying activity with $40.9M in transactions across all time.